Recruitment begins for a clinical trial of a COVID-19 vaccine led by Andy Pollard
Professor Andrew Pollard, Vice Master of St Cross College, is the Chief Investigator on a new study developing a possible vaccine for COVID-19. The 'ChAdOx1 nCoV-19' vaccine, as it is called, was developed by a team of University of Oxford researchers based on an adenovirus vaccine vector. A collaborative team from the Jenner Group and the Oxford Vaccine Group is now recruiting over 500 healthy volunteers for clinical trials of the vaccine. While applications for volunteers have closed, those interested in volunteering for future COVID-19 studies can register interest here.
Pollard is one of a team of academics, which includes himself, Professor Sarah Gilbert, Professor Teresa Lambe, Dr Sandy Douglas and Professor Adrian Hill, who began the project on Friday 10 January 2020. Pollard said, ‘Starting the clinical trials is the first step in the efforts to find out whether the new vaccine being developed at Oxford University works and could safely play a central role in controlling the pandemic coronavirus that is sweeping the globe.’
You can read more about the study here.
7 April 2020